110 related articles for article (PubMed ID: 2195867)
1. Fibrinolysis and fibrinogenolysis in liver disease.
Takahashi H; Tatewaki W; Wada K; Niwano H; Shibata A
Am J Hematol; 1990 Aug; 34(4):241-5. PubMed ID: 2195867
[TBL] [Abstract][Full Text] [Related]
2. Fibrinolysis and fibrinogenolysis in disseminated intravascular coagulation.
Takahashi H; Tatewaki W; Wada K; Niwano H; Shibata A
Thromb Haemost; 1990 Jun; 63(3):340-4. PubMed ID: 2402738
[TBL] [Abstract][Full Text] [Related]
3. The fibrinogen degradation products (FgDP) levels in liver disease.
Song KS; Kim HS; Park KE; Kwon OH
Yonsei Med J; 1993 Sep; 34(3):234-8. PubMed ID: 8259700
[TBL] [Abstract][Full Text] [Related]
4. Fibrinolysis and fibrinogenolysis in patients with thrombotic disease.
Takahashi H; Wada K; Hanano M; Niwano H; Takizawa S; Yazawa Y; Shibata A
Blood Coagul Fibrinolysis; 1992 Apr; 3(2):193-6. PubMed ID: 1606291
[TBL] [Abstract][Full Text] [Related]
5. [Differentiation between fibrin degradation products and fibrinogen degradation products by using newly developed ELISAs].
Isogai N; Yamagishi T; Kaku M; Matsumoto K; Yamamoto Y; Kuroso K; Arai M; Yorifuji H; Fukutake K; Fujimaki M
Rinsho Byori; 1991 Jul; 39(7):753-7. PubMed ID: 1920869
[TBL] [Abstract][Full Text] [Related]
6. Correlations between plasma levels of fibrin(ogen) derivatives as quantified by different assays based on monoclonal antibodies.
Kroneman H; Nieuwenhuizen W; Knot EA; Van Bergen PF; De Maat MP
Thromb Res; 1991 Feb; 61(4):441-52. PubMed ID: 1953861
[TBL] [Abstract][Full Text] [Related]
7. Implications of fibrinogenolysis in patients with closed head injury.
Kushimoto S; Shibata Y; Yamamoto Y
J Neurotrauma; 2003 Apr; 20(4):357-63. PubMed ID: 12866815
[TBL] [Abstract][Full Text] [Related]
8. Is quantitative determination of fibrin(ogen) degradation products and thrombin-antithrombin III complexes useful to diagnose deep venous thrombosis in outpatients?
van Bergen PF; Knot EA; Jonker JJ; de Boer AC; de Maat MP
Thromb Haemost; 1989 Dec; 62(4):1043-5. PubMed ID: 2694421
[TBL] [Abstract][Full Text] [Related]
9. The use of high dose aprotinin in liver transplantation: the influence on fibrinolysis and blood loss.
Grosse H; Lobbes W; Frambach M; von Broen O; Ringe B; Barthels M
Thromb Res; 1991 Aug; 63(3):287-97. PubMed ID: 1720262
[TBL] [Abstract][Full Text] [Related]
10. [Fluctuation of plasma levels of fibrinogen degradation products, fibrin degradation products and total fibrin/fibrinogen degradation products in patients with DIC].
Isogai N; Kuroso K; Fujimaki M; Yorifuji H; Fukutake K
Rinsho Byori; 1993 Dec; 41(12):1349-52. PubMed ID: 8295346
[TBL] [Abstract][Full Text] [Related]
11. Plasma coagulation profiles in patients with severe primary pulmonary hypertension.
Hoeper MM; Sosada M; Fabel H
Eur Respir J; 1998 Dec; 12(6):1446-9. PubMed ID: 9877507
[TBL] [Abstract][Full Text] [Related]
12. [Differentiation of fibrinolysis and fibrinogenolysis by analysis of FDP fragments].
Okumura N; Furuwatari C; Ishikawa S; Furihata K; Katsuyama T; Kanai M; Nakahata T; Saitoh H
Rinsho Byori; 1992 Jul; 40(7):789-94. PubMed ID: 1507499
[TBL] [Abstract][Full Text] [Related]
13. Thrombin activation and increased fibrinolysis in patients with chronic liver disease.
Páramo JA; Rifón J; Fernández J; Cuesta B; Rocha E
Blood Coagul Fibrinolysis; 1991 Apr; 2(2):227-30. PubMed ID: 1909901
[TBL] [Abstract][Full Text] [Related]
14. Hemostatic imbalance in active and quiescent ulcerative colitis.
van Bodegraven AA; Schoorl M; Baak JP; Linskens RK; Bartels PC; Tuynman HA
Am J Gastroenterol; 2001 Feb; 96(2):487-93. PubMed ID: 11232695
[TBL] [Abstract][Full Text] [Related]
15. Markers of coagulation and fibrinolysis in portal blood from patients with and without gastric malignancy.
Rahr HB; Sørensen JV; Larsen JF; Jensen FS; Bredahl C
Scand J Gastroenterol; 1994 Jun; 29(6):516-21. PubMed ID: 8079109
[TBL] [Abstract][Full Text] [Related]
16. Markers of coagulation and fibrinolysis after fractures of the lower extremities.
Sørensen JV; Rahr HB; Jensen HP; Borris LC; Lassen MR; Ejstrud P
Thromb Res; 1992 Mar; 65(4-5):479-86. PubMed ID: 1615491
[TBL] [Abstract][Full Text] [Related]
17. Fibrinogen and fibrin degradation products in patients undergoing open-heart surgery.
Rifón J; Fernández J; Páramo JA; Cuesta B; Rocha E
Blood Coagul Fibrinolysis; 1990 Oct; 1(4-5):509-12. PubMed ID: 2133228
[TBL] [Abstract][Full Text] [Related]
18. Increased levels of fibrinolysis reaction products (D-dimer) in patients with decompensated alcoholic liver cirrhosis.
Gram J; Duscha H; Zurborn KH; Bruhn HD
Scand J Gastroenterol; 1991 Nov; 26(11):1173-8. PubMed ID: 1754853
[TBL] [Abstract][Full Text] [Related]
19. A comparative evaluation of assays for markers of activated coagulation and/or fibrinolysis: thrombin-antithrombin complex, D-dimer and fibrinogen/fibrin fragment E antigen.
Boisclair MD; Lane DA; Wilde JT; Ireland H; Preston FE; Ofosu FA
Br J Haematol; 1990 Apr; 74(4):471-9. PubMed ID: 2189490
[TBL] [Abstract][Full Text] [Related]
20. Markers of coagulation and fibrinolysis in blood drawn into citrate with and without D-Phe-Pro-Arg-Chloromethylketone (PPACK).
Rahr HB; Sørensen JV; Danielsen D
Thromb Res; 1994 Mar; 73(5):279-84. PubMed ID: 8016814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
